Prospective cohort study reports higher disease severity and inflammatory markers in children with adenoviral pneumonia and viremia, suggesting serious implications for management.
Key Points
To examine the clinical characteristics and inflammatory response in children with adenovirus viremia and pneumonia.
Conducted a prospective cohort study in a PICU setting.
Included children diagnosed with severe adenoviral pneumonia.
Compared clinical features and inflammatory markers between viremia and nonviremia groups.
Viremia was present in nearly 40% of children with pneumonia.
The viremia group exhibited higher sputum viral loads.
Inflammatory markers like CRP, PCT, IL-6, IL-8, IL-10, and IFN-γ levels were significantly elevated in the viremia group.
Children with viremia experienced more severe disease outcomes.